FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market
Story summaryThe U.S. Food and Drug Administration approved Eli Lilly's GLP-1 pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight-loss medications.
Read at CNBCOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.